Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Guiducci S, Girelli F, Riccieri V, Zanatta E, Bosello S, Cavazzana I, Ingegnoli F, Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Masini F, Gigante A, Bellando-Randone S, Pellegrino G, Pigatto E, Dall'Ara F, Lazzaroni MG, Generali E, Mennillo G, Barsotti S, Mariano GP, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Risa AM, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Doria A, Iannone F, Salvarani C, Matucci-Cerinic M, Ferri C; Systemic sclerosis PRogression INvestiGation group (SPRING). De Angelis R, et al. Among authors: cacciapaglia f. J Rheumatol. 2022 Feb;49(2):176-185. doi: 10.3899/jrheum.210794. Epub 2021 Nov 15. J Rheumatol. 2022. PMID: 34782448
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society for Rheumatology.
Cacciapaglia F, Spinelli FR, Erre GL, Gremese E, Manfredi A, Piga M, Sakellariou G, Viapiana O, Atzeni F, Bartoloni E. Cacciapaglia F, et al. Clin Exp Rheumatol. 2023 Sep;41(9):1784-1791. doi: 10.55563/clinexprheumatol/hyaki6. Epub 2023 Mar 2. Clin Exp Rheumatol. 2023. PMID: 36912349 Free article. Review.
Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study.
De Luca G, De Lorenzis E, Campochiaro C, Cacciapaglia F, Del Papa N, Zanatta E, Airò P, Lazzaroni MG, Giuggioli D, De Santis M, Alonzi G, Stano S, Binda M, Moccaldi B, Tonutti A, Cavalli S, Batani V, Natalello G, Iannone F, D'Agostino MA, Dagna L, Matucci-Cerinic M, Bosello SL. De Luca G, et al. Among authors: cacciapaglia f. Rheumatology (Oxford). 2024 May 15:keae280. doi: 10.1093/rheumatology/keae280. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38745439
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort.
Atzeni F, Cacciapaglia F, Galloways J, Manfredi A, Sakellariou G, Norton S, Gremese E, Spinelli FR, Viapiana O, Piga M, Erre GL, Bartoloni Bocci E. Atzeni F, et al. Among authors: cacciapaglia f. Autoimmun Rev. 2024 Feb;23(2):103478. doi: 10.1016/j.autrev.2023.103478. Epub 2023 Nov 11. Autoimmun Rev. 2024. PMID: 37956778
C-reactive protein level association with future cardiovascular events assessed by different risk scores among rheumatoid arthritis patients.
Erre GL, Bartoloni E, Viapiana O, Gremese E, Atzeni F; “Cardiovascular, Obesity and Rheumatic Disease Study (CORDIS) Group” of the Italian Society of Rheumatology (SIR). Erre GL, et al. Eur J Intern Med. 2023 May;111:120-121. doi: 10.1016/j.ejim.2023.03.017. Epub 2023 Mar 21. Eur J Intern Med. 2023. PMID: 36948976 No abstract available.
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.
Riccieri V, Pellegrino G, Cipolletta E, Giuggioli D, Bajocchi G, Bellando-Randone S, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Saccon F, Grazia Lazzaroni M, Franceschini F, Generali E, Mennillo G, Barsotti S, Pagano Mariano G, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Bianchi G, Conti F, Cozzi F, D'Angelo S, Doria A, Fusaro E, Govoni M, Guiducci S, Iannone F, Salvarani C, Sebastiani GD, Ferri C, Matucci-Cerinic M, De Angelis R. Riccieri V, et al. Among authors: cacciapaglia f. J Scleroderma Relat Disord. 2024 Feb;9(1):38-49. doi: 10.1177/23971983231209809. Epub 2024 Jan 11. J Scleroderma Relat Disord. 2024. PMID: 38333531
Janus kinase inhibitors: between prescription authorization and reimbursability.
Spinelli FR, Conti F, Caporali R, Iannone F, Cacciapaglia F, Steering Committee Of The Italian Society Of Rheumatology OBOT. Spinelli FR, et al. Among authors: cacciapaglia f. Reumatismo. 2023 Dec 19;75(4). doi: 10.4081/reumatismo.2023.1627. Reumatismo. 2023. PMID: 38115771 Free article.
108 results